Leukine
Payments companies reported to CMS as associated with Leukine. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Leukine, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Leukine
These are the largest totals companies reported as associated with Leukine. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hillard Lazarus | Cleveland, OH | Hematology & Oncology | $625,636.35 |
| Nicholas Dainiak | Bridgeport, CT | Internal Medicine | $339,294.66 |
| Sanjeev Ahuja | Carmel, IN | $30,375.00 | |
| Santosh Kesari | Santa Monica, CA | Neurology (Psychiatry & Neurology) | $30,030.05 |
| Bruce Trapnell | Cincinnati, OH | Pulmonary Disease | $15,596.65 |
| Rekha Abichandani | Cambridge, MA | Nephrology (Internal Medicine) | $7,785.00 |
| Tisha Wang | Los Angeles, CA | Critical Care Medicine (Internal Medicine) | $6,689.83 |
| Elinor Lee | Los Angeles, CA | Pulmonary Disease | $4,601.70 |
| David Lawson | Atlanta, GA | Medical Oncology | $4,000.00 |
| Joey Ead | Plantation, FL | Podiatrist | $3,100.00 |
Prescribed Leukine?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.